Masahiro Torasawa, Takehito Shukuya, Kohei Uemura, Takuo Hayashi, Toshihide Ueno, Shinji Kohsaka, Yoshihiro Masui, Yukina Shirai, Makiko Okura, Tetsuhiko Asao, Yoichiro Mitsuishi, Naoko Shimada, Fumiyuki Takahashi, Kazuya Takamochi, Kenji Suzuki, Kazuhisa Takahashi, Kuniaki Seyama
BACKGROUND AND OBJECTIVE: Lymphangioleiomyomatosis (LAM) is a rare neoplastic disease associated with the functional tumour suppressor genes TSC1 and TSC2 and causes structural destruction in the lungs, which could potentially increase the risk of lung cancer. However, this relationship remains unclear because of the rarity of the disease. METHODS: We investigated the relative risk of developing lung cancer among patients diagnosed with LAM between 2001 and 2022 at a single high-volume centre in Japan, using data from the Japanese Cancer Registry as the reference population...
April 23, 2024: Respirology: Official Journal of the Asian Pacific Society of Respirology